This NIDA R13 grant is designed to disseminate cutting-edge research in the areas of addictions and health disparities, while also supporting the professional development of Early Career Investigators (ECIs; graduate students, postdoctoral fellows, and new investigators within 10-years of completing their terminal research degree) at the annual convention of the American Psychological Association (APA). The APA is the largest organization of psychologists, their educators, and their trainees in the United States. The APA membership is comprised of a wide array of pre- and post-doctoral psychology trainees, early, mid-career, and senior researchers in psychology, and psychologists working in clinical practice, applied research, teaching, and administrative work. This NIDA R13 will be in partnership with two divisions within APA - Division 28 (Psychopharmacology and Substance Abuse) and Division 50 (Society of Addiction Psychology). These two divisions are replete with NIDA awardees and others devoted to drug- related research. The primary goals of this NIDA R13 are twofold: (1) to disseminate cutting-edge addictions research with an emphasis on health disparities affecting underserved and understudied communities. (2) To foster the development of the next generation of addictions researchers in the psychological community. The first goal will be achieved by supporting cutting-edge addictions research within the Division 28 and 50 conference programs. This will take in the form of travel support for speakers in two symposia and disseminated to conference attendees via a print Addictions and Health Disparities Research Highlights brochure, [division websites, electronic media, and social media platforms]. The second goal will be achieved by providing 30 travel awards to ECIs, hosting the ECI Poster Session and Social Hour, and [developing dynamic] ECI career development workshops [aimed at developing grantsmanship in addictions and health disparities research, networking with senior investigators, and integrating ECIs in future APA programming]. The goals of this grant are consistent with NIDA's Strategic Plan and every effort will be made to ensure NIDA R13 programming will be inclusive of women and underrepresented minorities.

Public Health Relevance

This project will have public health relevance by disseminating cutting-edge research in the areas of drug abuse and health-disparities. Presenters will be encouraged to share novel research, treatment, and prevention strategies that address cultural, linguistic, and structural barriers associated with engaging underserved/understudied communities. Finally, this project with provide professional development to Early-Career Investigators who represent the future in this critical area of scholarship, prevention, and intervention.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Conference (R13)
Project #
5R13DA038955-02
Application #
9207755
Study Section
Special Emphasis Panel (ZDA1-SXM-M (04)S)
Program Officer
Jones, Dionne
Project Start
2016-02-01
Project End
2019-01-31
Budget Start
2017-02-01
Budget End
2018-01-31
Support Year
2
Fiscal Year
2017
Total Cost
$25,000
Indirect Cost
Name
University of Houston
Department
Psychology
Type
Schools of Education
DUNS #
036837920
City
Houston
State
TX
Country
United States
Zip Code
77204
Piper, Brian J; DeKeuster, Rebecca M; Beals, Monica L et al. (2017) Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep. J Psychopharmacol 31:569-575